SB 1848
  • Introduced
    Jan 21, 2026
  • Passed Senate
  • Passed House
  • Became Law
SB 1848
Tennessee Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Controlled Substances - As introduced, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.
Last Action See all actions
Senate • Feb 11, 2026: Placed on Senate Health and Welfare Committee calendar for 2/18/2026
Latest Bill Text See all bill texts
Introduced

Summary

Comments on SB 1848

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Feb 11, 2026 | Senate
    • Placed on Senate Health and Welfare Committee calendar for 2/18/2026
  • Feb 02, 2026 | Senate
    • Passed on Second Consideration, refer to Senate Health and Welfare Committee
  • Jan 22, 2026 | Senate
    • Introduced, Passed on First Consideration
  • Jan 21, 2026 | Senate
    • Filed for introduction
Bill Texts
Documents
Sources